Constituents of Morning Glory as Anticancer Agents

Ipomoeassin compounds derived from morning glory plant material (especially Ipomoea sp. from Suriname) are useful as anti-cancer agents. The novel compounds also are useful for treating neurodegenerative disorders (such as Alzheimer's disease) in human patients.
Patent Information:
Title App Type Country Serial No. Patent No. File Date Issued Date Expire Date Patent Status
Morning Glory-Derived Anticancer Agents, and Novel Ipomoeassin Compounds US Utility *United States 11/366,806 7,560,536 3/3/2006 7/14/2009 8/15/2026 Issued
For Information, Contact:
Mike Miller
Senior Licensing Manager
Virginia Tech Intellectual Properties, Inc.
(540) 443-9228
David Kingston
Shugeng Cao
© 2020. All Rights Reserved. Powered by Inteum